US Paying Moderna $176 Million To Develop mRNA Bird Flu Jab For Humans

Fact checked by The People's Voice Community
Moderna

The US government want the vaccine manufacturer Moderna to develop a new mRNA vaccine that could treat bird flu, or H5N1, in people.

The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine that contains the same (deadly) mRNA technology as the company’s COVID-19 jab.

They say they wants to be “better prepared” for public-health crises, having “learned lessons from Covid”. Meanwhile Ferderal officials say concerns are growing across the country about cases in dairy cows infecting people.

According to AP:

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday.

The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program focusing on medical treatments for potential pandemics.

Moderna will launch trials to test the safety and effectiveness of a vaccine that could be used to scale up a response to a bird flu pandemic if needed.

The H5N1 virus was detected earlier this year in dairy cows and has spread to more than 135 herds in 12 states and infected three people to date, all with mild cases. Federal health officials stress that the risk to the wider population remains low.

Niamh Harris
About Niamh Harris 15152 Articles
I am an alternative health practitioner interested in helping others reach their maximum potential.